Comparing the Efficacy of Intra-Lesional Injection versus Systemic Steroids in Treating Idiopathic Granulomatous Mastitis
Objective: To compare the clinical efficacy, safety and patients satisfaction of intra-lesional steroid injections versus systemic steroid therapy in the management of idiopathic granulomatous mastitis (IGM) among female patients presenting to a tertiary care Hospital. Methods: This prospective comparative cohort study was carried out at general surgery department of LUMHS, from July 2025 to December 2025. Women patients aged >8 years, presented with suggestive of idiopathic granulomatous mastitis without prior corticosteroid treatment in the past 3 months were included. Patients were allocated to the intralesional corticosteroid injection group or the systemic corticosteroid group according to clinical decisions and preference of the patients. The cases of Group A received corticosteroid injections directly into the granulomatous lesions using a 22–23G needle under aseptic technique, under ultrasound guidance and cases of Group B received systemic corticosteroid treatment. Patients were followed up every two weeks during treatment and then at 1 and 3 months after completion the treatment. All the relevant data were entered and analyzed using SPSS version 26. Results: Mean age of the intralesional steroid group patients was 33.57 ± 7.25 years and systemic steroid group was 37.85 ± 6.58 years without significant difference (p = 0.114). Cases who were treated with intralesional steroids improved clinically significantly earlier (3.28 ± 1.48 vs 5.57 ± 2.13 weeks), (p = 0.003) and achieved quick complete resolution (7.57 ± 2.10 vs 10.57 ± 2.65 weeks), p = 0.002. Complete resolution rates were higher in intralesional steroids group (92.9% vs 78.6%) while statistically insignificant (p = 0.280), and no recurrence occurred in either group. Adverse effects were mild and local with intralesional injection, whereas the systemic group mainly experienced weight gain with bloating or anxiety (p = 0.031). Overall satisfaction was 85.7% with intralesional steroids and 57.1% with systemic steroids (p = 0.336). Conclusion: Both treatment approaches achieved the comparable resolution rates, while ILS injection can be considered a safe first-line alternative to systemic steroids in treating idiopathic granulomatous mastitis, with early improvement and resolution and very limited in ejection site related local side effects.
Authors
- Ambreen Munir (ORCID: https://orcid.org/0000-0003-3779-3959)
- Mujeeb-ur- Rehman
- Anita Kumari (ORCID: https://orcid.org/0009-0007-5667-0192)
- Shakila Jhatial
- Qurat ul Ain
- Rahmat Urf Sehrish Shah
Publication Details
- Journal
- Annals of PIMS-Shaheed Zulfiqar Ali Bhutto Medical University
- Published
- 2026-11-21
- DOI
- https://doi.org/10.48036/vgqgqz07
- Primary Topic
- Breast Lesions and Carcinomas
- Type
- article
- Field-Weighted Citation Impact
- 0.00